Author:
Yoon Ha Young,Ahn Min Hyoung,Yee Jeong,Lee Nari,Han Ji Min,Gwak Hye Sun
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference24 articles.
1. Perucca E (2002) Pharmacological and therapeutic properties of valproate. CNS Drugs 16:695–714
2. Jawien W, Wilimowska J, Klys M, Piekoszewski W (2017) Population pharmacokinetic modelling of valproic acid and its selected metabolites in acute VPA poisoning. Pharmacol Rep 69:340–349
3. Zhao M, Zhang T, Li G, Qiu F, Sun Y, Zhao L (2017) Associations of CYP2C9 and CYP2A6 polymorphisms with the concentrations of valproate and its hepatotoxin metabolites and valproate-induced hepatotoxicity. Basic Clin Pharmacol Toxicol 121:138–143
4. Wang C, Wang P, Yang LP, Pan J, Yang X, Ma HY (2017) Association of CYP2C9, CYP2A6, ACSM2A, and CPT1A gene polymorphisms with adverse effects of valproic acid in Chinese patients with epilepsy. Epilepsy Res 132:64–69
5. Sadeque AJ, Fisher MB, Korzekwa KR, Gonzalez FJ, Rettie AE (1997) Human CYP2C9 and CYP2A6 mediate formation of the hepatotoxin 4-ene-valproic acid. J Pharmacol Exp Ther 283:698–703
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献